Methylphenidate hydrochloride Prescribing at MAPLE ACCESS PARTNERSHIP LLP
CNS stimulants and drugs used for ADHD | Central Nervous System
Items (12m)
595
Total Quantity
10.2K
NHS Cost
£10.8K
vs National Avg
+130.4%
MAPLE ACCESS PARTNERSHIP LLP prescribed 595 items of Methylphenidate hydrochloride over the last 12 months at a cost of £10,841 to the NHS. This is 130.4% above the national average prescribing rate. Methylphenidate hydrochloride is classified under CNS stimulants and drugs used for ADHD in the BNF.
Monthly Prescribing Trend
Jun 2026
38
Jun 2026
37
Jun 2026
55
Jun 2026
30
Jun 2026
46
Jun 2026
51
Jun 2026
45
Jun 2026
43
Jun 2026
57
Jun 2026
75
Jun 2026
58
Jun 2026
60
Prescribing Details
| Total Items | 595 |
|---|---|
| Total Quantity | 10,233 |
| Total NHS Cost | £10,841 |
| Presentations | 32 different forms |
| vs National Average | +130.4% |
Methylphenidate hydrochloride Prescribing Comparison
| This practice | 595 items |
|---|---|
| National average per practice | 258 items |
| Difference | +130.4% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.